A biochip-based combined immunoassay for detection of serological status of Borrelia burgdorferi in Lyme borreliosis.
CONCLUSIONS: The combined biochip-based immunoassay, as a potential substitution of ELISA, provided a promising approach to extend the detection spectrum of infectious antibodies against a panel of Borrelia antigens.
PMID: 28676442 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Chemistry - Category: Chemistry Authors: Huang NL, Ye L, Lv H, Du YX, Schneider M, Fan LB, Du WD Tags: Clin Chim Acta Source Type: research